TÜRKÇE
ENGLISH
Information
| Unit | FACULTY OF PHARMACY |
| PHARMACY PR. | |
| Code | ECS504 |
| Name | Pharmacogenetics |
| Term | 2020-2021 Academic Year |
| Semester | 10. Semester |
| Duration (T+A) | 2-0 (T-A) (17 Week) |
| ECTS | 3 ECTS |
| National Credit | 2 National Credit |
| Teaching Language | Türkçe |
| Level | Lisans Dersi |
| Type | Normal |
| Label | E Elective |
| Mode of study | Uzaktan Öğretim |
| Catalog Information Coordinator | Prof. Dr. FATMA AYDINOĞLU |
| Course Instructor |
Prof. Dr. FATMA AYDINOĞLU
(Bahar)
(A Group)
(Ins. in Charge)
|
Course Goal / Objective
Describe to pharmacogenetic, personalize therapy and evaluate and explain to the role of genetic varieties on pharmacokinetic and pharmacodynamic characteristics, drug interactions and pharmacogenetic in clinic
Course Content
Genetic and environmental factors in individual variability, pharmacogenetic and individual therapy, the role of genetic factors in the pharmacokinetic/pharmacodinamic properties, the effect of genetic factors in individual drug responses, gene therapy
Course Precondition
Resources
Notes
Course Learning Outcomes
| Order | Course Learning Outcomes |
|---|---|
| LO01 | Explain to pharmacogenetic and personalized therapy |
| LO02 | Explain the contribution of genetic and environmental factors in interpersonal variability in responses to drugs |
| LO03 | Explain the mechanism of genetic factors in changes in drug pharmacokinetics |
| LO04 | To explain the alterations of drug pharmacodynamic due to genetic factors |
| LO05 | Explain to the possible enzyme polymorphism caused pharmacokinetic alterations |
| LO06 | Explain to importance of pharmacogenetic in personalized therapy |
| LO07 | Explain to pharmacogenetic in clinical trials and pharmacogenetic tests |
| LO08 | Describe to current studies in pharmacogenetic |
Relation with Program Learning Outcome
| Order | Type | Program Learning Outcomes | Level |
|---|---|---|---|
| PLO01 | Bilgi - Kuramsal, Olgusal | Have sufficient knowledge in pharmaceutical field and develop the knowledge. | |
| PLO02 | Bilgi - Kuramsal, Olgusal | Comprehends professional knowledge with ethical responsibility through current laws and legislation. | |
| PLO03 | Beceriler - Bilişsel, Uygulamalı | Provides consultancy service to patients, community and health care personnel and evaluates advanced knowledge and skills with a critical approach. | 3 |
| PLO04 | Beceriler - Bilişsel, Uygulamalı | Possessing the knowledge of historical and current developments in the field of Pharmacy, monitoring, evaluation and application of scientific and evidence-based data, and adopting lifelong learning. | 3 |
| PLO05 | Beceriler - Bilişsel, Uygulamalı | Have the knowledge and skills to help provide patient-oriented pharmacy applications and individualized pharmaceutical care by learning the basics of Clinical Pharmacy, | |
| PLO06 | Yetkinlikler - Bağımsız Çalışabilme ve Sorumluluk Alabilme Yetkinliği | Takes a role in the evaluation and analysis of the events and cases related to the development of pharmacy profession and education. | 3 |
| PLO07 | Yetkinlikler - Öğrenme Yetkinliği | Integrates and develops professional knowledge via different disciplines and uses the acquired knowledge to improve the health level and quality of life of the community. | 4 |
| PLO08 | Yetkinlikler - Öğrenme Yetkinliği | Use effectively the concepts and applications of basic sciences and basic medical sciences in the field of medicine and pharmacy and update the information. | |
| PLO09 | Yetkinlikler - İletişim ve Sosyal Yetkinlik | Communicates effectively in writing and speaking. | |
| PLO10 | Yetkinlikler - İletişim ve Sosyal Yetkinlik | Practices the profession in accordance with Atatürk's principles and reforms, equipped with universal knowledge, uses Turkish correctly and knows at least one foreign language. | |
| PLO11 | Yetkinlikler - İletişim ve Sosyal Yetkinlik | Be an example to society withexternal appearance, demeanor, attitude and behavior for the other professionals and society and with professional identity | |
| PLO12 | Yetkinlikler - Alana Özgü Yetkinlik | Have knowledge about health policies and health economics, pharmacy management and define the problems in pharmaceutical field. | |
| PLO13 | Yetkinlikler - Alana Özgü Yetkinlik | Interprets information about current health and treatment problems and attends meeting on related matters . Plays an active role in community health. | 3 |
| PLO14 | Yetkinlikler - Alana Özgü Yetkinlik | Acquires basic information about diseases, makes decisions about the drugs used in treatment in accordance with rational drug use. |
Week Plan
| Week | Topic | Preparation | Methods |
|---|---|---|---|
| 1 | Evaluation of the contribution of genetic and environmental factors in interpersonal variability in responses to drugs | Reviews relevant book and literature | |
| 2 | Pharmacogenetic and personalized therapy | Reviews relevant book and literature | |
| 3 | Current studies on individual differences, pharmacogenetics and individual treatment in response to drugs | Reviews literature | |
| 4 | İnvestigation polymorphism of enzymes contributed to drug biotransformation | Reviews relevant book and literature | |
| 5 | Pharmacogenetic of trasnporter proteins | Reviews relevant book and literature | |
| 6 | Current literature on changes in genetic factors in drug pharmacokinetics | Reviews literature | |
| 7 | The alterations of drug pharmacodynamic due to genetic factors-1 | Reviews relevant book and literature | |
| 8 | Mid-Term Exam | ||
| 9 | The alterations of drug pharmacodynamic due to genetic factors-2 | Reviews relevant book and literature | |
| 10 | Current literature on changes in genetic factors in drug pharmacodinamic | Reviews literature | |
| 11 | The alterations of drug interactions due to genetic factors | Reviews relevant book and literature | |
| 12 | The importance of pharmacogenetics in personalized therapy | Reviews relevant book and literature | |
| 13 | Pharmacogenetic in clinical trials and pharmacogenetic tests | Reviews relevant book and literature | |
| 14 | Pharmacogenetic researches | Reviews literature | |
| 15 | Gene therapy and current studies | Reviews literature | |
| 16 | Term Exams | ||
| 17 | Term Exams |
Assessment (Exam) Methods and Criteria
| Assessment Type | Midterm / Year Impact | End of Term / End of Year Impact |
|---|---|---|
| 1. Midterm Exam | 100 | 40 |
| General Assessment | ||
| Midterm / Year Total | 100 | 40 |
| 1. Final Exam | - | 60 |
| Grand Total | - | 100 |
Student Workload - ECTS
| Works | Number | Time (Hour) | Workload (Hour) |
|---|---|---|---|
| Course Related Works | |||
| Class Time (Exam weeks are excluded) | 14 | 2 | 28 |
| Out of Class Study (Preliminary Work, Practice) | 14 | 2 | 28 |
| Assesment Related Works | |||
| Homeworks, Projects, Others | 0 | 0 | 0 |
| Mid-term Exams (Written, Oral, etc.) | 1 | 6 | 6 |
| Final Exam | 1 | 16 | 16 |
| Total Workload (Hour) | 78 | ||
| Total Workload / 25 (h) | 3,12 | ||
| ECTS | 3 ECTS | ||